Clinical Trials Directory

Trials / Completed

CompletedNCT02259049

The Effects of L-Tyrosine on 24 Hour Blood Pressure and Heart Rate in Parkinson's Disease

The Effects of L-Tyrosine on Non-invasive Ambulatory Blood Pressure and Heart Rate Monitoring in Parkinson's Disease

Status
Completed
Phase
EARLY_Phase 1
Study type
Interventional
Enrollment
6 (actual)
Sponsor
New York Institute of Technology · Academic / Other
Sex
All
Age
40 Years – 84 Years
Healthy volunteers
Not accepted

Summary

The investigators are observing the effects 2,000 mg of L-tyrosine will have on 24 hour blood pressure fluctuations in individuals with Parkinson's disease.

Detailed description

We will be monitoring 24 hour ambulatory BP and HR in subjects with PD on 3 separate visits. The first visit will be without an intervention to establish a baseline of 24 hour BP fluctuations. One week later the subject will be given either L-tyrosine (2,000 mg) with B6 (10 mg) or a sugar pill. We will monitor 24 hour BP and HR after supplementation. One week later the subject will repeat the same procedures with either supplement or placebo. This is a total of 3 visits with 24 hour ambulatory BP and HR monitoring.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTL-tyrosineEach subject will receive 2,000 mg of L-tyrosine BID for 24 hours.
DIETARY_SUPPLEMENTSugar PillEach subject will receive a sugar pill BID for 24 hours.

Timeline

Start date
2014-10-01
Primary completion
2015-09-01
Completion
2015-09-01
First posted
2014-10-08
Last updated
2016-01-20

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02259049. Inclusion in this directory is not an endorsement.